These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia. Hankins JS, Wynn LW, Brugnara C, Hillery CA, Li CS, Wang WC. Br J Haematol; 2008 Jan; 140(1):80-5. PubMed ID: 17991298 [Abstract] [Full Text] [Related]
4. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration. Brugnara C. J Pediatr Hematol Oncol; 2003 Dec; 25(12):927-33. PubMed ID: 14663274 [Abstract] [Full Text] [Related]
5. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, Alper SL, Platt OS. J Clin Invest; 1996 Mar 01; 97(5):1227-34. PubMed ID: 8636434 [Abstract] [Full Text] [Related]
6. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. De Franceschi L, Saadane N, Trudel M, Alper SL, Brugnara C, Beuzard Y. J Clin Invest; 1994 Apr 01; 93(4):1670-6. PubMed ID: 7512989 [Abstract] [Full Text] [Related]
8. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease. Brugnara C. Curr Opin Hematol; 1995 Mar 01; 2(2):132-8. PubMed ID: 9371983 [Abstract] [Full Text] [Related]
9. Therapeutic strategies for prevention of sickle cell dehydration. Brugnara C. Blood Cells Mol Dis; 2001 Mar 01; 27(1):71-80. PubMed ID: 11358364 [Abstract] [Full Text] [Related]
10. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. Bookchin RM, Ortiz OE, Lew VL. J Clin Invest; 1991 Jan 01; 87(1):113-24. PubMed ID: 1702096 [Abstract] [Full Text] [Related]
11. [Clinical trials of new therapeutic pharmacology for sickle cell disease]. Brugnara C, de Franceschi L. Sante; 2006 Jan 01; 16(4):263-8. PubMed ID: 17446160 [Abstract] [Full Text] [Related]
13. Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells. Muzyamba MC, Gibson JS. J Physiol; 2003 Mar 15; 547(Pt 3):903-11. PubMed ID: 12576491 [Abstract] [Full Text] [Related]
14. Membrane transport of Na and K and cell dehydration in sickle erythrocytes. Brugnara C. Experientia; 1993 Feb 15; 49(2):100-9. PubMed ID: 8440348 [Abstract] [Full Text] [Related]
15. Sodium-potassium pump, ion fluxes, and cellular dehydration in sickle cell anemia. Izumo H, Lear S, Williams M, Rosa R, Epstein FH. J Clin Invest; 1987 Jun 15; 79(6):1621-8. PubMed ID: 3034977 [Abstract] [Full Text] [Related]
16. Sickle cell dehydration: Pathophysiology and therapeutic applications. Brugnara C. Clin Hemorheol Microcirc; 2018 Jun 15; 68(2-3):187-204. PubMed ID: 29614632 [Abstract] [Full Text] [Related]
17. Ion transport pathology in the mechanism of sickle cell dehydration. Lew VL, Bookchin RM. Physiol Rev; 2005 Jan 15; 85(1):179-200. PubMed ID: 15618480 [Abstract] [Full Text] [Related]
18. Cation transport and volume regulation in sickle red blood cells. Joiner CH. Am J Physiol; 1993 Feb 15; 264(2 Pt 1):C251-70. PubMed ID: 8447360 [Abstract] [Full Text] [Related]
19. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP. Medicine (Baltimore); 1996 Nov 15; 75(6):300-26. PubMed ID: 8982148 [Abstract] [Full Text] [Related]
20. Erythrocyte membrane transport physiology. Brugnara C. Curr Opin Hematol; 1997 Mar 15; 4(2):122-7. PubMed ID: 9107529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]